BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 27029490)

  • 21. The effect of maternal exposure to psychosocial job strain on pregnancy outcomes and child development.
    Larsen AD
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network.
    Petersen I; Gilbert RE; Evans SJ; Man SL; Nazareth I
    J Clin Psychiatry; 2011 Jul; 72(7):979-85. PubMed ID: 21457681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of maternal mental health service users treated with mood stabilizing or antipsychotic medication.
    Møller-Olsen C; Friedman SH; Prakash C; North A
    Asia Pac Psychiatry; 2018 Jun; 10(2):e12304. PubMed ID: 29226616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study.
    Vigod SN; Gomes T; Wilton AS; Taylor VH; Ray JG
    BMJ; 2015 May; 350():h2298. PubMed ID: 25972273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: A multicentre study.
    Galbally M; Frayne J; Watson SJ; Morgan V; Snellen M
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):63-69. PubMed ID: 31141172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal antipsychotic exposure and neuromotor performance during infancy.
    Johnson KC; LaPrairie JL; Brennan PA; Stowe ZN; Newport DJ
    Arch Gen Psychiatry; 2012 Aug; 69(8):787-94. PubMed ID: 22474072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study.
    Vigod SN; Kurdyak PA; Dennis CL; Gruneir A; Newman A; Seeman MV; Rochon PA; Anderson GM; Grigoriadis S; Ray JG
    BJOG; 2014 Apr; 121(5):566-74. PubMed ID: 24443970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes.
    Cohen JM; Huybrechts KF; Patorno E; Desai RJ; Mogun H; Bateman BT; Hernández-Díaz S
    J Clin Psychiatry; 2019 Jun; 80(4):. PubMed ID: 31237992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription of Sodium Valproate as a Mood Stabiliser in Pregnancy.
    Womersley K
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):679-684. PubMed ID: 28953852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study.
    Habermann F; Fritzsche J; Fuhlbrück F; Wacker E; Allignol A; Weber-Schoendorfer C; Meister R; Schaefer C
    J Clin Psychopharmacol; 2013 Aug; 33(4):453-62. PubMed ID: 23764684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.
    Hu J; McMillan SS; Theodoros T; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
    BMC Psychiatry; 2022 Nov; 22(1):705. PubMed ID: 36380352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder].
    Samalin L; Arnould A; Boudieu L; Henry C; Haffen E; Drapier D; Anmella G; Pacchiarotti I; Vieta E; Belzeaux R; Llorca PM
    Encephale; 2022 Dec; 48(6):624-631. PubMed ID: 36257849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of severe relapse in pregnant women with psychotic or bipolar disorders.
    Taylor CL; Broadbent M; Khondoker M; Stewart RJ; Howard LM
    J Psychiatr Res; 2018 Sep; 104():100-107. PubMed ID: 30015264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.
    Hayes J; Prah P; Nazareth I; King M; Walters K; Petersen I; Osborn D
    PLoS One; 2011; 6(12):e28725. PubMed ID: 22163329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States.
    Park Y; Huybrechts KF; Cohen JM; Bateman BT; Desai RJ; Patorno E; Mogun H; Cohen LS; Hernandez-Diaz S
    Psychiatr Serv; 2017 Nov; 68(11):1112-1119. PubMed ID: 28617210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating mood disorders during pregnancy: safety considerations.
    Eberhard-Gran M; Eskild A; Opjordsmoen S
    Drug Saf; 2005; 28(8):695-706. PubMed ID: 16048355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.